MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis

NCT06434376 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: Conventional chemotherapy combined with personalized immune regulation diagnosis and treatment technology

Sponsor

Second Affiliated Hospital of Wenzhou Medical University